Global API Market Outlook 2020

08 Oct, 2015, 12:10 ET from Research and Markets

DUBLIN, Oct. 08 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/vwlc5m/global_api_market) has announced the addition of the "Global API Market Outlook 2020" report to their offering.

The global API market has been garnering a lot of attention since the last few years. In, Global API Market Outlook 2020, the growth of the global API market has been forecasted by looking at the current market trends. This market is expected to grow at a CAGR of 6.5% from 2014-2020. The market has been segmented by type of manufacturing, type of drug, type of API and by therapeutic segment; and each segment's market has also been forecasted.

The market has been divided into four major geographies which comprise of North America, Asia Pacific, Europe and the Rest of the World. For every region, the current and future outlook of the API sector has been provided. A future opportunity assessment of every region has also been done to help highlight the areas with promising possibilities.

Excellent growth has been witnessed in pharmaceutical industry in emerging markets. Rising affordability, enhanced life expectancy and improved standard of living are all providing impetus to the demand of pharmaceuticals. However, major regulatory changes in the United States and Europe are set to change the API landscape. As patterns in developed regions continue to remain flat and opportunities for growth shift from traditional markets, the API industry is expected to witness the rise of second wave emerging markets, such as India and China.

As the days of the blockbuster drugs start waning, more flexible manufacturing focused on personalized medicine can be seen as the future of the pharmaceutical business. The report elaborates on the rise of more such trends and challenges, and their possible impacts on the industry.

We have also covered the key players in the Merchant API Market. For every player, a brief business overview, geographical revenue break up, and segment-wise revenue break up has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global API market.

Key Topics Covered:

1. Analyst View

2. Research Methodology

3. APIs - An Introduction

4. Global API Industry

5. Drivers & Challenges

6. Market Segmentation

7. Trends and Developments

8. Competitive Landscape

- Aurobindo Pharma Limited
- BASF SE
- Boehringer Ingelheim GmbH
- Divis Laboratories Limited
- Dr. Reddy's Laboratories
- Kyowa Hakko Kirin
- Lonza
- Pfizer
- Royal DSM
- Teva Active Pharmaceuticals Ingredients

For more information visit http://www.researchandmarkets.com/research/vwlc5m/global_api_market

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com